N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell lines. | Cell Death Differ;11(5): 527-41, 2004 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell lines.

Cuello, M; Coats, A O; Darko, I; Ettenberg, S A; Gardner, G J; Nau, M M; Liu, J R; Birrer, M J; Lipkowitz, S.

Affiliation

Cuello M; Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892-4255, USA.

Cell Death Differ ; 11(5): 527-41, 2004 May.

Article in En | MEDLINE | ID: mdl-14765134

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Membrane Glycoproteins / Tumor Necrosis Factor-alpha / Fenretinide / Apoptosis / Retinoid X Receptors / Mitochondria Limits: Female / Humans Language: En Journal: Cell Death Differ Year: 2004 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Membrane Glycoproteins / Tumor Necrosis Factor-alpha / Fenretinide / Apoptosis / Retinoid X Receptors / Mitochondria Limits: Female / Humans Language: En Journal: Cell Death Differ Year: 2004 Document type: Article Affiliation country: